Cronos Group Inc. (CRON) P/E Ratio History
UndervaluedTrading at 21.6x vs 5Y avg 95.9x · 47th percentile · Below historical baseline · Data 2016–2026
Loading P/E history...
P/E Ratio Analysis
As of November 8, 2026, Cronos Group Inc. (CRON) trades at a price-to-earnings ratio of 21.6x, with a stock price of $3.61 and trailing twelve-month earnings per share of $0.17.
The current P/E is 77% below its 5-year average of 95.9x. Over the past five years, CRON's P/E has ranged from a low of 2.6x to a high of 486.1x, placing the current valuation at the 47th percentile of its historical range.
Compared to the Healthcare sector median P/E of 24.6x, CRON is roughly in line with its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 196.0x.
Relative to the broader market, CRON trades roughly in line with the S&P 500 median P/E of 21.8x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CRON DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CRON Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
CRON P/E vs Peers
Cannabis Producers & Brands peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 10.9Lowest | 2.92 | -29% | |
| $4B | 36.1 | - | -29% | |
| $31M | 15.0 | - | -77% | |
| $127B | 15.7 | 1.38Best | -37% | |
| $308B | 28.9 | 4.09 | +61% | |
| $24B | 12.6 | - | +2236%Best |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
CRON Historical P/E Data (2016–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q3 | Sep 30 2026 | $3.30 | $0.15 | 21.4x | -78% |
| FY2026 Q2 | - | $2.78 | $0.18 | 15.4x | -84% |
| FY2025 Q3 | - | $2.78 | $0.09 | 30.0x | -69% |
| FY2025 Q2 | Jun 30 2025 | $1.91 | $0.05 | 40.3x | -58% |
| FY2025 Q1 | Mar 31 2025 | $1.81 | $0.12 | 14.5x | -85% |
| FY2024 Q4 | - | $2.02 | $0.10 | 19.6x | -80% |
| FY2020 Q3 | Sep 30 2020 | $5.01 | $0.23 | 21.8x | -77% |
| FY2020 Q2 | - | $6.01 | $1.67 | 3.6x | -96% |
| FY2020 Q1 | - | $5.67 | $2.14 | 2.6x | -97% |
| FY2019 Q4 | - | $7.67 | $2.27 | 3.4x | -96% |
| FY2019 Q3 | Sep 30 2019 | $9.05 | $2.06 | 4.4x | -95% |
| FY2019 Q2 | Jun 30 2019 | $15.98 | $0.41 | 38.7x | -60% |
| FY2019 Q1 | Mar 31 2019 | $18.43 | $0.26 | 72.1x | -25% |
| FY2018 Q2 | Jun 30 2018 | $6.52 | $0.02 | 370.5x | +286% |
| FY2018 Q1 | Mar 31 2018 | $6.73 | $0.02 | 425.9x | +344% |
| FY2017 Q4 | Dec 31 2017 | $7.73 | $0.02 | 486.1x | +407% |
| FY2017 Q3 | Sep 30 2017 | $2.10 | $0.02 | 103.1x | +7% |
| FY2017 Q2 | Jun 30 2017 | $1.33 | $0.01 | 138.4x | +44% |
| FY2016 Q3 | Sep 30 2016 | $0.68 | $0.07 | 10.5x | -89% |
Average P/E for displayed period: 95.9x
CRON Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CRON — Frequently Asked Questions
Quick answers to the most common questions about buying CRON stock.
What is CRON's P/E ratio?
Cronos Group Inc. (CRON) trailing twelve-month P/E ratio is 21.6x, based on TTM diluted EPS of $0.17. The 5-year average P/E is 95.9x and the historical range spans 2.6x to 486.1x.
Is CRON stock overvalued or undervalued?
CRON trades at 21.6x P/E, below its 5-year average of 95.9x. At the 47th percentile of its historical range (2.6x–486.1x), the stock is priced at a discount to its own history.
Is CRON stock expensive?
No, CRON is not expensive on a historical basis. The current P/E of 21.6x is below the 5-year average of 95.9x and sits at the 47th percentile of its valuation range.
What is CRON's historical P/E range?
Over the past 5 years, CRON's P/E ratio has ranged from 2.6x to 486.1x, with a median of 21.8x and an average of 95.9x. The current P/E of 21.6x places the stock at the 47th percentile of this range. Full historical data spans 2016–2026.
How does CRON's P/E compare to the S&P 500?
CRON trades at 21.6x P/E versus the S&P 500 median of 21.8x. The 1% discount to the market suggests lower growth expectations or perceived higher risk.
How does CRON's valuation compare to Healthcare peers?
Cronos Group Inc. P/E of 21.6x compares to the Healthcare sector median of 24.6x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is CRON's PEG ratio?
CRON PEG ratio is N/A, based on a P/E of 21.6x and EPS growth of -122.8%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is CRON's earnings yield?
CRON earnings yield is 4.63%, the inverse of its 21.6x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.